Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chadi Nabhan

Showing results (61-70 of 199) with videos related to

Pageof 20
Sort By:
Leukemia Research|April 8, 2004
Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new eraChadi Nabhan, Ronald B Gartenhaus, Martin S Tallman
Leukemia Research|January 15, 2008
Controversies in the front-line management of chronic lymphocytic leukemiaChadi Nabhan, Tait D Shanafelt, Neil E Kay
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2019
Value in Oncology: It Is in the Eyes of the BeholderChadi Nabhan, Eli G Phillips, Bruce A Feinberg
JAMA Oncology|July 28, 2017
Minimal Residual Disease in Chronic Lymphocytic Leukemia in the Era of Novel Agents: A ReviewMeghan Thompson, Danielle Brander, Chadi Nabhan, et al.
JAMA Oncology|August 8, 2020
Rethinking Clinical Trials Reform During the COVID-19 PandemicChadi Nabhan, Toni K Choueiri, Anthony R Mato
JAMA|May 18, 2016
Surveillance Imaging in Patients in Remission From Hodgkin and Diffuse Large B-Cell LymphomaChadi Nabhan, Sonali M Smith, Adam S Cifu
Oncology (Williston Park, N.Y.)|March 14, 2003
Current status of monoclonal antibody therapy for chronic lymphocytic leukemiaChadi Nabhan, Martin J Dyer, Steven T Rosen
Leukemia & Lymphoma|October 1, 2011
Maintenance rituximab in follicular non-Hodgkin lymphoma: facts and controversiesChadi Nabhan, Sonali M Smith, Brad S Kahl
JAMA|August 26, 2015
Prostate Cancer ScreeningScott E Eggener, Adam S Cifu, Chadi Nabhan
Leukemia & Lymphoma|January 9, 2018
Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndromeJenna Janiga, Jonathan Kentley, Chadi Nabhan, et al.
Pageof 20

Showing results (61-70 of 199) with videos related to

Sort By:
Pageof 20
Leukemia Research|April 8, 2004
Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new eraChadi Nabhan, Ronald B Gartenhaus, Martin S Tallman
Leukemia Research|January 15, 2008
Controversies in the front-line management of chronic lymphocytic leukemiaChadi Nabhan, Tait D Shanafelt, Neil E Kay
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2019
Value in Oncology: It Is in the Eyes of the BeholderChadi Nabhan, Eli G Phillips, Bruce A Feinberg
JAMA Oncology|July 28, 2017
Minimal Residual Disease in Chronic Lymphocytic Leukemia in the Era of Novel Agents: A ReviewMeghan Thompson, Danielle Brander, Chadi Nabhan, et al.
JAMA Oncology|August 8, 2020
Rethinking Clinical Trials Reform During the COVID-19 PandemicChadi Nabhan, Toni K Choueiri, Anthony R Mato
JAMA|May 18, 2016
Surveillance Imaging in Patients in Remission From Hodgkin and Diffuse Large B-Cell LymphomaChadi Nabhan, Sonali M Smith, Adam S Cifu
Oncology (Williston Park, N.Y.)|March 14, 2003
Current status of monoclonal antibody therapy for chronic lymphocytic leukemiaChadi Nabhan, Martin J Dyer, Steven T Rosen
Leukemia & Lymphoma|October 1, 2011
Maintenance rituximab in follicular non-Hodgkin lymphoma: facts and controversiesChadi Nabhan, Sonali M Smith, Brad S Kahl
JAMA|August 26, 2015
Prostate Cancer ScreeningScott E Eggener, Adam S Cifu, Chadi Nabhan
Leukemia & Lymphoma|January 9, 2018
Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndromeJenna Janiga, Jonathan Kentley, Chadi Nabhan, et al.
Pageof 20